Australasian Journal of Dermatology

Papers
(The median citation count of Australasian Journal of Dermatology is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Poster Presentations24
Dermoscopy, confocal microscopy and optical coherence tomography features of main inflammatory and autoimmune skin diseases: A systematic review24
Carbon footprint of dermatologic surgery20
SARS‐CoV‐2 (COVID‐19) vaccination in dermatology patients on immunomodulatory and biologic agents: Recommendations from the Australasian Medical Dermatology Group19
Successful secukinumab treatment of active bullous pemphigoid and chronic severe psoriasis: a case report18
Extragenital lichen sclerosus: A comprehensive review17
Management of hypertrophic scars in adults: A systematic review and meta‐analysis17
Tildrakizumab as a potential long‐term therapeutic agent for severe Hidradenitis Suppurativa: A 15 months experience of an Australian institution16
Legal and ethical considerations of artificial intelligence in skin cancer diagnosis16
Defining the incidence of cutaneous squamous cell carcinoma in coastal NSW Australia15
An unusual presentation of pemphigus foliaceus following COVID‐19 vaccination15
A narrative review of the roles of topical permethrin and oral ivermectin in the management of infantile scabies14
Toxic epidermal necrolysis and Stevens‐Johnson syndrome after COVID‐19 infection and vaccination13
Pityriasis rosea‐like eruption revealing COVID‐1913
Topical simvastatin–cholesterol for disseminated superficial actinic porokeratosis: An open‐label, split‐body clinical trial13
Effective treatment of oral lichen planus with the JAK inhibitor baricitinib13
Paediatric and Adolescent Dermatology13
Probiotic mixture reduces gut inflammation and microbial dysbiosis in children with atopic dermatitis13
Successful treatment of chronic severe alopecia areata with abrocitinib13
Systematic review of sirolimus in dermatological conditions12
Tissue eosinophil levels as a marker of disease severity in bullous pemphigoid12
Dupilumab‐associated psoriasis and psoriasiform dermatitis in patients with atopic dermatitis12
Two cases of vitiligo vulgaris treated with topical Janus kinase inhibitor delgocitinib11
Is methotrexate hepatotoxicity associated with cumulative dose? A systematic review and meta‐analysis11
Treatment of granuloma annulare with tofacitinib10
Secukinumab use in the treatment of Netherton's syndrome10
Mucormycosis with cutaneous involvement. A retrospective study of 115 cases at a tertiary care hospital in Mexico10
VEXAS syndrome: A dermatological perspective10
Clinical characteristics and predictive factors of erythema nodosum in granulomatous lobular mastitis10
Quality of life of women with untreated vulval lichen sclerosus assessed with vulval quality of life index (VQLI)10
Efficacy of topical versus intradermal injection of Tranexamic Acid In Egyptian melasma Patients: A randomised clinical trial10
Congenital melanocytic naevi: An up‐to‐date overview10
Successful management of treatment resistant nail psoriasis with tildrakizumab9
Dermoscopy and reflectance confocal microscopy of intraepidermal Merkel cell carcinoma9
Clinical and histopathological features of onychopapilloma in an Australian setting: A case series of 50 patients9
Combination treatment with monoclonal antibodies: Secukinumab, benralizumab and dupilumab for the combined management of psoriasis and severe asthma9
Novel combination biologic therapy for recalcitrant psoriasis and psoriatic arthritis in a medically complex patient9
Segmental stiff skin syndrome (SSS): Clinical case and a brief review9
Factors associated with high Altmetric Attention Score in dermatology research9
Disseminated superficial actinic porokeratosis following hydroxyurea treatment: A case report8
Dupilumab successfully treated refractory bullous pemphigoid with early clinical manifestations imitating atopic dermatitis: A case letter8
Itraconazole in the treatment of basal cell carcinoma: A case‐based review of the literature8
Thalidomide for prevention of camrelizumab‐induced reactive cutaneous capillary endothelial proliferation8
A machine‐learning modified CART algorithm informs Merkel cell carcinoma prognosis8
Successful treatment of calciphylaxis in a renal transplant recipient with combination of intralesional sodium thiosulphate, intravenous sodium thiosulphate and fish skin graft8
Challenges and pitfalls between lichen planus pemphigoides and bullous lichen planus8
Vulval lichen sclerosus: An Australasian management consensus8
Topical epigallocatechin‐3‐gallate in the treatment of vitiligo8
A practical guide on the use of imiquimod cream to treat lentigo maligna8
Onychopapilloma presenting as longitudinal melanonychia: A case report and literature review8
Misdiagnoses and barriers to care in hidradenitis suppurativa: A patient survey8
Successful treatment of pityriasis rubra pilaris with tildrakizumab8
Pembrolizumab associated Stevens–Johnson syndrome with porokeratosis in a patient in the setting of primary hepatocellular carcinoma7
Nine cases of chronic hand and foot eczema treated with baricitinib7
Association study of transition of laboratory marker levels and transition of disease activity of atopic dermatitis patients treated with dupilumab7
Epidemiological, clinical, pathological and genetic characteristics of epidermolysis bullosa in New Zealand7
Combination treatment of bilateral periocular sebaceous carcinomas with microsatellite instability with neoadjuvant pembrolizumab and Mohs surgery7
Cutaneous manifestations and dermatological sequelae of Covid‐19 infection compared to those from other viruses7
Characteristics of 637 melanomas documented by 27 general practitioners on the Skin Cancer Audit Research Database7
A case of treatment‐resistant pityriasis rubra pilaris responsive to secukinumab7
A case of toxic epidermal necrolysis after ChAdOx1 nCov‐19 (AZD1222) vaccination7
A long‐term cohort study of acitretin for prevention of keratinocyte carcinoma in solid organ transplant recipients7
Successful treatment of vulvovaginal lichen planus with tildrakizumab: A case series of 24 patients7
Reactive perforating collagenosis successfully treated with dupilumab6
Fractional carbon dioxide laser for treating hypertrophic scars: A systematic review of randomised trials6
Five years of dermatological disease requiring specialist care in the Kimberley region of Western Australia6
Characteristics, treatment and outcomes of 589 melanoma patients documented by 27 general practitioners on the Skin Cancer Audit Research Database6
Multicentric reticulohistiocytosis revealing breast cancer: Report of a case with dermoscopic, radiological and therapeutic aspects6
6
The impact of incomplete clinical information and initial biopsy technique on the histopathological diagnosis of cutaneous melanoma6
Clustering trends of melanoma incidence and mortality: A worldwide assessment from 1995 to 20196
Ultrasound‐guided de‐roofing of epithelialised tunnels of hidradenitis suppurativa6
Subacute cutaneous lupus erythematosus induced by PD‐1 Inhibitor therapy: two case reports and literature review6
SUFU‐associated Gorlin syndrome: Expanding the spectrum between classic nevoid basal cell carcinoma syndrome and multiple hereditary infundibulocystic basal cell carcinoma6
Secukinumab treatment demonstrated high drug survival and sustained effectiveness in patients with severe chronic plaque psoriasis: 21‐month analysis in Australian routine clinical practice (SUST6
A casemix study of patients seen within an urban Aboriginal Health Service dermatology clinic over a five‐year period6
Appropriate indication and procedure for random skin biopsy in the diagnosis of intravascular large B‐cell lymphoma6
Ultraviolet filter, fragrance and preservative allergens in New Zealand sunscreens6
Oral mycophenolate mofetil in the treatment of acquired dermal macular hyperpigmentation: An open‐label pilot study6
Bowel‐associated dermatosis–arthritis syndrome (BADAS)6
Medical Dermatology6
First report of cutaneous mycetoma by Paecilomyces variotii and the successful treatment with combined itraconazole and terbinafine along with resection surgeries5
Ulcerating necrobiosis lipoidica successfully treated with ustekinumab5
Incidence and prevalence of alopecia areata in the Australian primary care setting: A retrospective analysis of electronic health record data5
Dermoscopic features of primary cutaneous amyloidosis in skin of colour: A retrospective analysis of 48 patients from South India5
Adult female acne: Clinical characteristics and factors significantly associated with polycystic ovary syndrome5
Melanoma/Oncology5
Cutaneous adverse reactions following the Pfizer/BioNTech COVID‐19 vaccine5
Australian Teledermatology experience during COVID‐195
Informing a position statement on the use of artificial intelligence in dermatology in Australia5
Differences in the skin microbial community between patients with active and stable vitiligo based on 16S rRNA gene sequencing5
Moisturisers from birth in at‐risk infants of atopic dermatitis – a pragmatic randomised controlled trial5
Bullous pemphigoid associated with anti‐programmed cell death protein 1 and anti‐programmed cell death ligand 1 therapy: A case series of 13 patients5
Neutrophilic dermatosis: a new skin manifestation and novel pathogenic variant in a rare autoinflammatory disease5
Talimogene laherparepvec resulting in near‐complete response in a patient with treatment‐refractory Merkel cell carcinoma5
A real‐world Australian experience of upadacitinib for the treatment of severe atopic dermatitis5
Efficacy of ustekinumab and guselkumab in treatment refractory pityriasis rubra pilaris: A case series5
PD‐1 inhibitors for cutaneous squamous cell carcinoma: A meta‐analysis5
Dupilumab‐associated ocular surface disease: An interdisciplinary decision framework for prescribers in the Australian setting5
Increased risk of herpes zoster in patients with psoriasis: A longitudinal follow‐up study using a national sample cohort5
Highlighting adalimumab as a treatment option for systemic treatment of toxic epidermal necrolysis: A case series from a tertiary specialised burns centre5
Onychomycosis in older adults: The age and associated factors affecting the complete cure rate5
Clobetasol propionate 0.05% under occlusion for alopecia areata: Clinical effect and influence on intraocular pressure5
Acquired idiopathic generalized anhidrosis diagnosed following mRNA COVID‐19 vaccination—A case series5
Histone deacetylase 1 in patients with alopecia areata and acne vulgaris: An epigenetic alteration4
Expression of programmed cell death ligand 1 (PD‐L1) at in situ and invasive extramammary Paget’s disease and literature review4
Treatment of dissecting cellulitis of the scalp with Tildrakizumab4
Scrutinising the role of simvastatin in a patient of Pachyonychia Congenita with KRT6A gene mutation4
Medical dermatology4
Baby wipes and nappy rash – what is the relationship? A review4
Long‐term dupilumab therapy in Netherton syndrome with severe atopic manifestations: Case report and review of the literature4
Linear lichen planus after COVID‐19 vaccination4
Blau syndrome with pulmonary nodule in a child4
A case of pityriasis rubra pilaris treated with tofacitinib after failure with acitretin and ixekizumab4
Relationship between PASI and FDLQI in paediatric psoriasis, and treatments used in daily clinical practice4
Effectiveness, safety and satisfaction of 1% tirbanibulin ointment in the treatment of actinic keratoses: A prospective study in real clinical practice4
PASI vs PO‐PASI: Patient‐Oriented PASI (PO‐PASI) is comparable to clinician score PASI4
The role of line‐field confocal optical coherence tomography (LC‐OCT) in the diagnosis of eccrine poroma: A case report4
The role of artificial intelligence language models in dermatology: Opportunities, limitations and ethical considerations4
Concurrent extramammary Paget's disease involving the genitalia and axilla: Case report and literature review4
Erythema multiforme following vaccination for SARS‐CoV‐2: Report of a case and review of the literature − Secondary Publication4
Pigmented purpuric dermatoses versus purpuric mycosis fungoides: Clinicopathologic similarities and new insights into dermoscopic features4
Mycosis fungoides and Sézary syndrome: Australian clinical practice statement4
Quantifying the ultraviolet radiation emitted by nail curing devices: A descriptive study4
Australian consensus: Treatment goals for moderate to severe psoriasis in the era of targeted therapies – Adult patients4
Diagnostic tools used for melanoma: A survey of Australian general practitioners and dermatologists4
Biologics/Psoriasis4
Management of multiple trichoepithelioma: A review of pharmacological therapies4
Benefits of skin application of piceatannol—A minireview4
Risk factors for cytomegalovirus reactivation in autoimmune bullous disease patients on immunosuppressive therapy4
Clinical and dermatoscopic characteristics of lichen planus‐like keratosis in a West‐Asian population4
Secukinumab and infectious adverse effects: A real‐life experience of 63 psoriasis patients4
Pyoderma gangrenosum: A review of patient's demographics, disease and treatment in 118 patients4
Evaluation of dynamic dermoscopic features of melanoma and benign naevi by sequential digital dermoscopic imaging and total body photography in a high‐risk Australian cohort4
Acquired causes of eyebrow and eyelash loss: A review and approach to diagnosis and treatment4
Merkel cell carcinoma in situ: A systematic review of prognosis and management4
Impact of COVID‐19 on inpatient dermatology consults in an Australian tertiary hospital4
Upadacitinib effectiveness in moderate‐to‐severe atopic dermatitis: A real‐life multicentre and retrospective study4
Drug‐induced cutaneous pseudolymphoma: A systematic review of the literature4
4
Development of melanoma clinical quality indicators for the Australian melanoma clinical outcomes registry (MelCOR): A modified Delphi study4
Epidemiology of eczema in South‐Eastern Australia3
Hyperkeratotic flexural erythema/granular parakeratosis responding to doxycycline3
Internalized stigma in chronic urticaria: A case–control study3
The value of adding platelet‐rich plasma (PRP) to noncultured epidermal cell suspension (NCECS) in surgical treatment of stable resistant vitiligo: A self‐controlled randomised d3
Eruptive Bowen's Disease in a patient on pembrolizumab for Hodgkin's lymphoma3
Quality of life impact and treatment response in vulval disease: Comparison of 3 common conditions using the Vulval Quality of Life Index3
Juvenile spring eruption among soldiers: A report of a large outbreak3
Assessment of potential predictive factors of dupilumab response in patients with moderate‐to‐severe atopic dermatitis3
Neoadjuvant intralesional methotrexate in small‐sized cutaneous squamous cell carcinoma: a prospective study in 84 patients3
A review of the cutaneous toxicities of tebentafusp—Featuring two cases involving superficial bullous reactions3
Platelet count and plateletcrit: Potential haematological biomarkers for livedoid vasculopathy?3
Roles of gut‐microbiota and probiotics in chronic urticaria: A systematic review and meta‐analysis3
Pseudoepitheliomatous keratotic and micaceous balanitis: A literature review3
The association between hidradenitis suppurativa and male and female infertility: A population‐based study3
Three cases of Sneddon syndrome: A comparison with lymphocytic thrombophilic arteritis3
Secukinumab treatment showed improved quality of life in patients with chronic plaque psoriasis in Australia: Results from the HOPE study3
Grenz ray therapy in disseminated superficial actinic porokeratosis: A case series of 17 patients3
Secondary alopecia induced by aesthetic procedures: An unrecognized potential complication3
Nail dystrophy as initial presentation of systemic amyloidosis3
CM‐AVM syndrome – A prospective observational study of unrelated paediatric cases3
Hypopigmented lesions in pityriasis lichenoides chronica patients: Are they only post‐inflammatory hypopigmentation?3
Is pyoderma gangrenosum associated with solid malignancies? Insights from a population‐based cohort study3
Diffuse congenital hypotrichosis simplex with associated hair shaft fragility3
Efficacy of switching from adalimumab originator to adalimumab biosimilar in moderate to severe psoriasis patients: A Real‐life experience in a tertiary referral centre3
Double vision due to lateral rectus injury after cosmetic botulinum toxin injections3
Inter‐ and intra‐patient heterogeneity of PD‐L1 expression in metastatic melanomas: A retrospective study3
Transient hypertriglyceridaemia associated with propranolol for treatment of infantile hemangioma3
Bullous pemphigoid in kidney transplant rejection: A case report and literature review3
Two cases of granular C3 dermatosis with intraepidermal neutrophilic and eosinophilic infiltration possibly induced by anti‐hypertensive drugs3
Not something to sit on: A case of senile gluteal dermatosis responding to calcipotriol ointment3
A case of lymphangioma circumscriptum with new reflectance confocal microscopy findings3
Subcutaneous panniculitis‐like T‐cell lymphoma in a 14‐year‐old female homozygous for HAVCR2 mutation3
Annular atrophic lichen planus induced by anti‐HER2 antibodies3
Efficacy and safety of tralokinumab in the treatment of head and neck pattern atopic dermatitis: A multicentre study of 12 patients3
Intravenous immunoglobulin treatment for refractory pyoderma gangrenosum3
Rivaroxaban in the treatment of TEK‐related venous malformation3
Successful treatment of idiopathic Harlequin Syndrome with oxybutynin and propranolol3
Remission of chronic spontaneous urticaria following omalizumab with gradually extended dosing intervals: Real‐life data3
Chemical peels for atrophic acne scarring: Evolution of peel types and methods3
Cutaneous squamous cell carcinoma metastatic to the axilla and groin: Outcomes and prognostic factors3
Melanoma diagnosis at a specialist dermatology practice without the use of photographic surveillance3
Serum levels and expression of IL‐25 in patients with psoriatic erythroderma3
Ustekinumab for the treatment of moderate‐to‐severe plaque psoriasis in a solid organ transplanted recipient: A case report3
A baseline patch test series for New Zealand3
Immunotherapy for the treatment of penile intraepithelial neoplasia associated with human papilloma virus type 16 using topical imiquimod and human papilloma virus vaccination3
Severe progressive scarring pembrolizumab‐induced lichen planopilaris in a patient with metastatic melanoma3
Why do some patients with vulval lichen sclerosus on long‐term topical corticosteroid treatment experience ongoing poor quality of life?3
Disease remission of refractory vulvovaginal and gingival lichen planus with tildrakizumab3
Knowledge and attitudes of Australian dermatologists towards sentinel lymph node biopsy for melanoma: a mixed methods study3
Comparison of cyclosporine and systemic corticosteroid for treating drug reaction with eosinophilia and systemic symptoms syndrome: A retrospective 20‐year single‐centre study in South Korea3
Burden of proof—Critical flaws in the recommendations from the commission on human medicines Isotretinoin expert working group3
Risk of subsequent keratinocyte carcinomas after a first diagnosis in Tasmania, Australia3
Comparison of the EUROIMMUN Dermatology Profile ELISA to the novel BIOCHIP Mosaic 7 for the diagnosis of immunobullous skin disease3
Hidradenitis suppurativa and Down syndrome in a single‐centre sample: A cross‐sectional study3
Dermatological services; patient profiling in a rural tertiary hospital3
Recurrent cutaneous hyalohyphomycosis secondary to Purpureocillium lilacinum in an immunocompetent individual3
Refractory Head and Neck atopic dermatitis pattern treated with Dupilumab: Allergic contact dermatitis caused by decyl glucoside. Should surfactants be patched?3
Erosive pustular dermatosis of the scalp‐like eruption from panitumumab3
Hypopigmented mycosis fungoides: A 48‐case retrospective series3
Dermoscopy of dermal duct tumour3
Miliaria crystallina induced by idarubicin and all‐trans‐retinoic acid: Two case reports3
Multi‐drug resistant dermatophyte infections in Western Sydney: A retrospective case series3
2
Sorafenib‐induced eccrine squamous syringometaplasia2
The impact of hidradenitis suppurativa on quality of life is worse than inflammatory bowel disease and myocardial infarction2
Fear of cancer recurrence in patients with non‐metastatic melanoma: Spanish validation and disease‐related factors2
Consumer perceptions on privacy and confidentiality in dermatology for 3D total‐body imaging2
Identifying predictors of systemic immunosuppressive treatment of vulvovaginal lichen planus: A retrospective cohort study of 122 women2
Two cases of acquired perforating dermatosis successfully treated with allopurinol2
Cutaneous T‐cell lymphoma mimicking palmoplantar pustular psoriasis: A rare variant2
Cross‐sectional study of pigmented lesions of the head and neck in adults aged 40 years and above2
Patient with eosinophilic dermatosis of myeloproliferative disease presenting with generalized erythematous plaques – Response to Ruxolitinib2
A case of omalizumab as a successful treatment for telangiectasia macularis eruptiva perstans2
Practitioner characteristics, diagnostic accuracy metrics and discovering‐individual with respect to 637 melanomas documented by 27 general practitioners on the Skin Cancer Audit Research Database2
Skin collision tumour and dermoscopic diagnosis of melanoma in situ and dilated pore of Winer2
Hair and Nails2
A case of spiny keratoderma associated with chronic kidney disease2
2
Primary cutaneous amyloidosis: A review of the available studies and gaps in data2
Treatment of severe, refractory pyoderma gangrenosum with infliximab, adalimumab and intravenous immunoglobulin2
An Australian tertiary hospital analysis of outpatient dermatology clinical and demographic characteristics2
Sustainable dermatology—A practical guide for the Australian dermatologist2
Photosensitive generalised guttate lichen sclerosus et atrophicus: A rare presentation2
The impact of systemic psoriasis treatments on human papillomavirus activation and propagation2
First report of Mal de Meleda with pseudo‐ainhum treated with gabapentin in a 17‐year‐old Chinese girl2
Intralesional 5‐fluorouracil as a management for cutaneous squamous cell carcinomas: A rural Australian retrospective case series2
Bullous pemphigoid: Its incidence, mortality and clinical outcome in New Zealand2
Auto‐antibody profile and clinical presentation of Vietnamese with systemic sclerosis2
Reconstruction of a full‐thickness upper third defect of the helix ear using a single‐stage chondrocutaneous composite transposition flap2
Childhood‐onset Takayasu arteritis presenting as pyoderma gangrenosum‐like vasculitic ulceration: Three case reports and a literature review2
Mental health, insomnia and suicidal ideation during treatment with apremilast2
2
Multiple lenvatinib‐associated skin ulcers: A case report and literature review2
Acute generalised exanthematous pustulosis after initiation of palbociclib therapy for metastatic breast cancer2
Nodular vasculitis during treatment with vedolizumab in a patient with ulcerative colitis2
A cross‐sectional study of depression and quality of life in psoriasis2
Neoplasia‐related spiny keratoderma: Dermoscopic findings of two cases and a literature review2
Toxic epidermal necrolysis in adult patients: Experience from the West Australian Collaboration2
The epidemiology of mycosis fungoides in New Zealand2
Bacillus thuringiensis: a causative agent of pitted keratolysis2
Demographic and epidemiological drivers of global burden of psoriasis2
Measuring the quality of skin cancer management in primary care: A scoping review2
Dual biologic therapy with Omalizumab and Dupilumab for refractory atopic disease2
Minimum labelling requirements for dermatology artificial intelligence‐based Software as Medical Device (SaMD): A consensus statement2
Reflectance confocal microscopy‐assisted diagnosis of lichen planus pigmentosus distributed along multiple unilateral Blaschko's lines in a child: A case report2
Three cases of symmetrical drug‐related intertriginous and flexural exanthema (SDRIFE) induced by proton‐pump inhibitors2
Localised bullous urticaria presenting as a pompholyx‐like eruption in the context of flucloxacillin2
Two cases of yellow urticaria revealing acute lithiasic biliary disease2
Warfarin‐induced skin necrosis after the use of an anticoagulation reversal agent2
0.037523031234741